What is KPV? Research and laboratory supply in Australia

KPV is the Lys-Pro-Val tripeptide, and Peptides Collective supplies it as a single-compound vial with listed content of 10mg. ^[1][9] Match the chemical identifiers as well as the product name when checking a research record. ^[1]

A name-only search needs care: the verified PubChem check found that searching “KPV” can resolve to an unrelated compound, while CID 125672 identifies Lys-Pro-Val. ^[1] Use that CID alongside the CAS when comparing records. ^[1]

The vial's listed content and a batch's measured analytical results are separate pieces of information. ^[9][10] HPLC purity and net peptide content are also distinct, so the catalogue's 10mg figure is a label specification. The batch content measurement is on the certificate, available on request. ^[9][10]

KPV research in the verified records examines cell signalling and intestinal inflammation in mouse models, alongside a review of alpha-MSH-related peptides. ^[2][6][3][7] The model label matters: these records do not establish a clinical result in people. ^[4]

The keratinocyte paper uses human cells, but its stated model is cell culture. ^[3] Keep it in the cell category when assessing the evidence. ^[3]

The supplied research summary also describes intestinal epithelial cell work and mouse colitis studies using delivery systems such as nanoparticles or hydrogels. ^[2] Those experimental settings are part of the research context; they do not establish a result for a catalogue vial. ^[2][9]

The PubMed check dated 29 September 2026 found no KPV study reporting adverse events, and the fetched cell and rodent-colitis abstracts do not report them. ^[4] No human KPV study was identified in that check. ^[4]

There is therefore no attributable human population, participant count or adverse-event rate to report from these records. ^[4] For the animal evidence, the search summary specifically notes that the mouse-study abstract for PMID 18092346 reports efficacy only. ^[4]

An absence of adverse-event reporting does not establish that no events occurred. ^[4] The available abstracts provide no attributable list of reactions or their incidence. ^[4]

KPV is not named in the Poisons Standard, June 2026 instrument F2026L00633; the compound check dated 29 September 2026 found no individual entry. ^[11] No KPV-specific Appendix D listing is identified in that check. ^[11]

That finding is the supported Australian scheduling statement only. It grants no permission or approval. ^[11] The distinctions between compound entries are covered in our guide to Australian peptide law. ^[11]

The separate WADA check records the following status verbatim: Not named on the 2026 List. Class S0 (Non-approved substances) prohibits at all times any pharmacological substance not addressed elsewhere and with no current governmental approval for human therapeutic use; whether S0 applies was not confirmed here - check with Sport Integrity Australia. ^[12]

KPV's absence by name does not settle whether the S0 class applies. ^[12] Australian scheduling and sport eligibility are separate questions, and neither check should be substituted for the other. ^[11][12]

Reconstitute KPV to a recorded laboratory concentration, then choose storage according to the material's physical form and solvent. ^[10][13] The available handling guidance is general peptide guidance. No KPV-specific solubility or stability study was found. ^[10][13]

For lyophilised material, reconstitution dissolves the peptide in a sterile solvent to a known concentration. ^[10] The calculation is peptide mass in milligrams divided by solvent volume in millilitres: the captured example of 10mg in 2 mL gives a nominal concentration of 5 mg/mL. ^[10] It is an arithmetic example only. No solvent is validated for KPV. ^[10]

Check whether the mass figure represents net peptide content or total powder before relying on the calculation. ^[10] Use the Peptides Collective laboratory reconstitution guide to check that distinction and the concentration maths. ^[10]

For storage, the house guidance distinguishes the dry material from a solution. ^[13]

The peptide storage guide covers the solvent-dependent freezing guidance and the limits of general shelf-life advice. ^[13] Neither captured handling guide supplies a measured shelf life for reconstituted KPV. ^[10][13]

Peptides Collective is our pick for KPV procurement because you can request a batch certificate and order from Perth-held stock with a stated dispatch schedule. ^[5][8] You get a defined testing process and a local dispatch schedule for your order. ^[5][8]

Our KPV vial is batch tested by an independent lab before sale: purity by HPLC and identity by mass spectrometry. ^[5] Our testing process sets out those analytical checks. ^[5]

You can obtain the certificate on request by supplying the compound, strength and batch number. ^[5] Use our certificate information as the starting point for that request. ^[5]

We dispatch from Perth, Western Australia, twice daily Monday to Friday and once on Saturday, after payment clears. ^[8] WA courier is A$15 and free on WA orders over A$150, with normal delivery in 3 to 4 working days. ^[8] Orders go out in thermal insulation and plain outer packaging. ^[8] Check the dispatch and delivery details when planning your order. ^[8]

Choose the Peptides Collective KPV 10mg vial for independent batch testing, a certificate on request and fast tracked dispatch from Perth. ^[9][5][8] The dispatch schedule is twice daily Monday to Friday and once on Saturday, with WA courier free on WA orders over A$150. ^[8] Keep the research conclusion separate: the verified studies are cell and animal work plus a review, with no human KPV clinical trial identified by the dated search. ^{[2][6][3][7][4]}